The open short positions in TLG as of Monday 9th May are now at a record high of 1,519,944 shares.
The net open short position increased by 256,426 shares, on a total traded volume of the 1.5M shares. So at least 1 in 6 share traded on the 9/5 were short sales. This excludes any short sales that were opened and closed out the same day.
The share price fell another 10c over the rest of the week, with just of 3M shares traded.
I'll be interested to see if the open shorts increase or decrease over this period.
The open net short position has increased by ~600k shares, since the last SP peak of $1.74, on the 21/4.
There is a very strong support level around $1.225 over the past 18 months trading, so I do not see any great gains, subject to no Black Swan events, being made shorting Talga at these levels.
With major news on resource upgrades, permitting, financing and purchase agreements due over the next 6 months, I would not like to be trying to buy back +1.5M shares when these announcements start dropping.
- Forums
- ASX - By Stock
- TLG
- TLG Short's
TLG Short's, page-13
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLG (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.020(5.56%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
37.5¢ | 38.5¢ | 37.0¢ | $319.9K | 848.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 80096 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 79880 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 78096 | 0.370 |
3 | 72052 | 0.365 |
27 | 330591 | 0.360 |
4 | 30860 | 0.355 |
13 | 138482 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 79880 | 1 |
0.385 | 38165 | 3 |
0.390 | 3700 | 1 |
0.395 | 70975 | 2 |
0.400 | 9536 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
TLG (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online